Monopar Therapeutics Stock Forecast

Sell candidate since Nov 14, 2025 Loss -2.01%

The Monopar Therapeutics Inc. stock price fell by -2.01% on the last day (Monday, 17th Nov 2025) from $78.00 to $76.43. During the last trading day the stock fluctuated 11.03% from a day low at $75.71 to a day high of $84.06. The price has fallen in 6 of the last 10 days and is down by -9.01% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -96 thousand shares and in total, 177 thousand shares were bought and sold for approximately $13.55 million.

Given the current short-term trend, the stock is expected to rise 95.58% during the next 3 months and, with a 90% probability hold a price between $149.49 and $246.69 at the end of this 3-month period.

MNPR Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Monopar Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $81.64 and $86.12. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, October 13, 2025, and so far it has fallen -25.11%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Monopar Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $66.64 and $66.25. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Monopar Therapeutics Inc. finds support just below today's level at $66.64. If this is broken, then the next support from accumulated volume will be at $66.25 and $63.29.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $8.35 between high and low, or 11.03%. For the last week, the stock has had daily average volatility of 9.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MNPR) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Monopar Therapeutics Inc. to open at $78.73, and during the day (based on 14 day Average True Range), to move between $72.88 and $79.98, which gives a possible trading interval of +/-$7.11 (+/-9.75%) up or down from last closing price. If Monopar Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 9.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $78.00 (2.05%) than the support at $66.64 (12.81%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Monopar Therapeutics Inc. stock A Buy?

The Monopar Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Monopar Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.469 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $78.73 ( 3.01%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk